Helen Torley - Net Worth and Insider Trading
Helen Torley Net Worth
The estimated net worth of Helen Torley is at least $40 Million dollars as of 2024-11-05. Helen Torley is the PRESIDENT AND CEO of Halozyme Therapeutics Inc and owns about 676,744 shares of Halozyme Therapeutics Inc (HALO) stock worth over $40 Million. Helen Torley is also the Director of Relypsa Inc and owns about 1,237 shares of Relypsa Inc (RLYP) stock worth over $39,572. Details can be seen in Helen Torley's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Helen Torley has not made any transactions after 2024-10-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Helen Torley
Helen Torley Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Helen Torley owns 3 companies in total, including Halozyme Therapeutics Inc (HALO) , Quest Diagnostics Inc (DGX) , and Relypsa Inc (RLYP) .
Click here to see the complete history of Helen Torley’s form 4 insider trades.
Insider Ownership Summary of Helen Torley
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2024-10-09 | director & President and CEO |
| DGX | Quest Diagnostics Inc | 2018-05-15 | director |
| RLYP | Relypsa Inc | 2016-09-01 | director |
Helen Torley Latest Holdings Summary
Helen Torley currently owns a total of 2 stocks. Among these stocks, Helen Torley owns 676,744 shares of Halozyme Therapeutics Inc (HALO) as of October 9, 2024, with a value of $40 Million and a weighting of 99.9%. Helen Torley also owns 1,237 shares of Relypsa Inc (RLYP) as of June 7, 2016, with a value of $39,572 and a weighting of 0.1%.
Latest Holdings of Helen Torley
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2024-10-09 | 676,744 | 58.72 | 39,738,408 |
| RLYP | Relypsa Inc | 2016-06-07 | 1,237 | 31.99 | 39,572 |
Holding Weightings of Helen Torley
Helen Torley Form 4 Trading Tracker
According to the SEC Form 4 filings, Helen Torley has made a total of 23 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 23 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 20,000 shares on October 9, 2024, which brought Helen Torley around $1 Million.
According to the SEC Form 4 filings, Helen Torley has made a total of 0 transactions in Relypsa Inc (RLYP) over the past 5 years. The most-recent trade in Relypsa Inc is the sale of 1,013 shares on June 7, 2016, which brought Helen Torley around $19,571.
Insider Trading History of Helen Torley
- 1
Helen Torley Trading Performance
Helen Torley Ownership Network
Ownership Network List of Helen Torley
Ownership Network Relation of Helen Torley
Helen Torley Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
Helen Torley is the director & President and CEO of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , SVP & Chief Financial Officer Nicole Labrosse , and SVP & General Counsel Mark Howard Snyder .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, Helen Torley made 7 insider transaction in Halozyme Therapeutics Inc (HALO) with a net sale of 200,000. Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 49,881 shares made by Matthew L. Posard , and a net sale of 35,000 shares made by Nicole Labrosse .
In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
Helen Torley Mailing Address
Above is the net worth, insider trading, and ownership report for Helen Torley. You might contact Helen Torley via mailing address: C/o Onyx Pharmaceuticals, Inc., 249 East Grand Ave., South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
